久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Ortho Dermatologics Resubmits NDA for Duobrii americanpharmaceuticalreview
    August 16, 2018
    Ortho Dermatologics has resubmitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Duobrii (halobetasol propionate and tazarotene) (IDP-118) lotion in the treatment of plaque psoriasis.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service